Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Necrosis Factor Alpha”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01887314
What this trial is testing

Efficacy Study of Ginger (Zingiber Officinale) Extract "Ginpax" to Manage Nausea in Cancer Patients Receiving High Emetogenic Treatments and Standard Anti-emetogenic Therapy

Who this might be right for
CancerNauseaVomiting
Helsinn Healthcare SA 250
Early research (Phase 1)Study completedNCT00193648
What this trial is testing

Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Focal Glomerulosclerosis
Northwell Health 21
Testing effectiveness (Phase 2)Study completedNCT01714726
What this trial is testing

Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.

Who this might be right for
Crohn's Disease
AstraZeneca 121
Large-scale testing (Phase 3)UnknownNCT06135259
What this trial is testing

Topical Erythropoietin Hydrogel in Management of Oral Lichen Planus

Who this might be right for
Oral Lichen Planus
Ain Shams University 18
Testing effectiveness (Phase 2)Study completedNCT02437253
What this trial is testing

Effects of Adalimumab in Mucopolysaccharidosis Types I, II and VI

Who this might be right for
Mucopolysaccharidosis Type IMucopolysaccharidosis Type IIMucopolysaccharidosis Type VI
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center 2
Post-approval studies (Phase 4)Study completedNCT00636142
What this trial is testing

Effects of Infliximab on Insulin Sensitivity and Beta Cell Function in Insulin Resistant Human Obesity

Who this might be right for
ObesityInsulin ResistanceMetabolic Syndrome
Medical University of Graz 9
Large-scale testing (Phase 3)Study completedNCT00001296
What this trial is testing

Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma

Who this might be right for
Melanoma
National Cancer Institute (NCI) 122
Not applicableStudy completedNCT07237906
What this trial is testing

Neutropenia With TNF-α Inhibitors

Who this might be right for
NeutropeniaTNF-alpha Inhibitors
Burak Ugur Cetin 122
Early research (Phase 1)Active Not RecruitingNCT06125197
What this trial is testing

Oncolytic Adenovirus TILT-123 With Pembrolizumab as Treatment for Refractory Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
TILT Biotherapeutics Ltd. 22
Post-approval studies (Phase 4)Study completedNCT02092467
What this trial is testing

Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Pfizer 4,372
Large-scale testing (Phase 3)Study completedNCT01385826
What this trial is testing

Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis

Who this might be right for
UveitisJuvenile Arthritis
Assistance Publique - Hôpitaux de Paris 34
Post-approval studies (Phase 4)Study completedNCT04953871
What this trial is testing

Enthesitis Assessment Before and After Anti-Tumor Necrosis Factor Treatment in Spondyloarthritis

Who this might be right for
SpondyloarthritisEnthesitisAnti-Tumor Necrosis Factor Drugs
Gunay ER 31
Large-scale testing (Phase 3)Study completedNCT00552344
What this trial is testing

Evaluate Safety of Long Term Therapy of Certolizumab Pegol Patients With Crohn's Disease

Who this might be right for
Crohn Disease
UCB BIOSCIENCES GmbH 403
Not applicableUnknownNCT00925249
What this trial is testing

Comparison of the Tuberculin Skin Test (TST) and QuantiFERON ®-TB Gold Test (QFT-G) In Patients With Rheumatoid Arthritis Being Considered for Anti-TNF-Alpha Therapy

Who this might be right for
Rheumatoid ArthritisTuberculosis
Walter Reed Army Medical Center 90
Early research (Phase 1)Study completedNCT01899755
What this trial is testing

Evaluate the Pharmacokinetics (PK), Safety and Tolerability, Immunogenicity, and Pharmacodynamics (PD) of GSK2800528 in Healthy Subjects.

Who this might be right for
Psoriasis
GlaxoSmithKline 45
Testing effectiveness (Phase 2)UnknownNCT05755685
What this trial is testing

Hyperthermic Intraperitoneal Treatment of rmhTNF for CRCPM: Phase II Clinical Trial

Who this might be right for
Peritoneal MetastasesColorectal Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 10
Not applicableUnknownNCT03823482
What this trial is testing

Lidocaine and Perioperative Cytokine Levels in Blood and Cerebrospinal Fluid in Cerebral Aneurysm Patients

Who this might be right for
Aneurysm, Cerebral
Clinical Hospital Centre Zagreb 40
Testing effectiveness (Phase 2)WithdrawnNCT01269203
What this trial is testing

Efficacy of NF-kB Inhibition for Reducing Symptoms During Maintenance Therapy in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
M.D. Anderson Cancer Center
Not applicableEnded earlyNCT00477191
What this trial is testing

Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis

Who this might be right for
PsoriasisMetabolic SyndromeHyperlipidemia+2 more
Massachusetts General Hospital 18
Not applicableWithdrawnNCT02031211
What this trial is testing

TNF-alpha Inhibition in CRPS: A Randomized Controlled Trial

Who this might be right for
CRPSChronic Regional Pain Syndrome
Stanford University
Next Page